Organizational structure and educational components of pharmacoeconomic fellowship programs: A fellows' perspective

American Journal of Pharmaceutical Education

Volumn 67, Issue 4, 2003, Pages

  Maio, Vittorio ^a   Lofland, Jennifer H ^a,h   Doan, QuynhChau ^b   Duttagupta, Sandeep ^c   Khan, Zeba M ^d   Phillips, Amy L ^e   Sansgiry, Sujit S ^f   Shah, Amishi B ^c   Sung, Jennifer ^d   Yokoyama, Krista ^g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c PFIZER INC   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e ABBOTT LABORATORIES   (United States)

^f UNIVERSITY OF HOUSTON   (United States)

^g Wellpoint Inc   (United States)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Fellowship; Outcomes; Pharmacoeconomics; Postgraduate training

Indexed keywords

EID: 0442307492     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj6704105     Document Type: Review

References (15)

1. Elixhauser A, Halpern M, Schmier J, Luce BR. Health care CBA and CEA from 1991 to 1996: an updated bibliography. Med Care. 1998;36(5 Suppl):MS1-9.
2. Pritchard C. Trends in economic evaluation: OHE briefing No. 36. London: Office of Health Economics, 1998.
3. Drummond M, Dubois D, Garattini L, et al. Current trends in the use of pharmacoeconomics and outcomes research in Europe. Value Health. 1999; 2: 323-32.
4. Mullins CD, Ogilvie S. Emerging standardization in Pharmacoeconomics. Clin Ther. 1998; 20: 1194-1202.
5. Suh DC, Okpara IR, Agnese WB, Toscani M. Application of pharmacoeconomics to formulary decision making in managed care organizations. Am J Managed Care. 2002;8:161-9.
6. Jackson TR, Draugalis JR. Graduate pharmacoeconomic and outcomes research educational programs in colleges and schools of pharmacy: a five-year update. Am J Pharm Educ. 2000; 64:11-4.
7. Copley-Merriman K, Vanscoy G, Angaran D, et al. Panel 4: education and skills needed to conduct, interpret, and use economic evaluations in health-care. Value Health. 1999; 2:88-91.
8. Lee J, Lawrence BJ, Sullivan SD, et al. Guidelines for pharmacoeconomic research fellowship. Pharmacotheraphy. 1999; 19: 1105-9.
9. Maio V, Girts TK, Lofland JH, Nash DB. Pharmacoeconomic fellowships: the need for outcomes measures. Pharmacoeconomics. 2001;19:795-802.
10. International Society for Pharmacoeconomics and Outcomes Research. ISPOR directory of fellowships in pharmacoeconomics, health economics, outcomes research or related field of study. Available at: http://www.ispor.org/ fellowships_directory.htm. Accessed September 11, 2001.
11. American College of Clinical Pharmacy. ACCP directory of residencies and fellowships. Available at: www.accp.com/resandfel/. Accessed September 12, 2001.
12. Standards for fellowship training in pharmacoeconomics and outcomes research. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) position statement. May 1998: 1-6.
13. Babbie ER. The Basics of Social Research. 2nd ed. Belmont, Calif: Wadsworth/Thomson Learning, 2002.
14. Schleyer TKL, Forrest JL. Methods for the design and administration of web-based surveys. J Am Med Inform Assoc. 2000; 7:416-25.
15. Maio V, Lofland JH, Nash DB. Pharmacoeconomic fellowships: preceptors' views regarding adherence to the American College of Clinical Pharmacy guidelines. Am J Pharm Educ. 2003; 67(3): Article 75.